| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.7 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.079 | 0.7 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.069 | 0.7 |